PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Disease Rare Diseases 2,212 170 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Disease Gastroesophageal Reflux Disease 7,437 457 0.01 -0.97 0.06 0.55
Cancer 1,053,491 Disease Drug Acarbose (Precose)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Ancobon (Flucytosine)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Disease Sepsis 64,798 2,693 0.01 -0.98 0.04 0.55
Cancer 1,053,491 Disease Disease Hepatitis 163,842 5,739 0.01 -0.98 0.04 0.55
Cancer 1,053,491 Disease Disease Diverticulitis 4,735 323 0.00 -0.97 0.07 0.55
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Target CXCL11 526 55 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Target CXCL10 2,386 188 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target CER 2,421 197 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Drug Actos (Pioglitazone Hydrochloride)- FDA 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Disease Gallstones 8,280 540 0.01 -0.97 0.07 0.55
Cancer 1,053,491 Disease Target D-Dimer 6,185 428 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target B2M 677 72 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target Collagenase 3 367 45 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Target Dihydrofolate Reductase 5,563 401 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target CD146 729 79 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Disease Pneumonia 81,521 3,526 0.01 -0.98 0.04 0.56
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Disease Ovarian Cyst 1,959 178 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CCL5 2,002 186 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Drug Kaempferol 2,992 258 0.00 -0.96 0.09 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Liver Disease 49,817 2,478 0.01 -0.97 0.05 0.56